Smarter Decisions,
Better Care
UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point of care decisions.
For more information, click below.
Subscribers log in here
Related articles
| AuthorsMadhura Tamhankar, MDNicholas J Volpe, MD | Section EditorPaul W Brazis, MD | Deputy EditorJanet L Wilterdink, MD |
Topic Outline
INTRODUCTION
Ischemic optic neuropathy is the most common optic nerve disorder in patients over age 50 years [1]. Ischemic optic neuropathy is generally categorized as anterior (affecting the optic disc) versus posterior (retrobulbar) and as arteritic versus nonarteritic. Anterior involvement is common with both arteritic and nonarteritic ischemic optic neuropathy.
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy. It is an idiopathic, ischemic insult of the optic nerve head characterized by acute, monocular, painless visual loss with optic disc swelling.
This topic will discuss the clinical features, and diagnosis of NAION. The epidemiology, pathogenesis, etiologies, prognosis, and treatment of NAION are discussed separately. Other forms of ischemic optic neuropathy and other optic neuropathies are discussed separately. (See "Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies" and "Nonarteritic ischemic optic neuropathy: Prognosis and treatment" and "Clinical manifestations of giant cell (temporal) arteritis" and "Optic neuropathies".)
SYMPTOMS
Affected patients describe a sudden onset of monocular vision loss or visual field loss. This is often noticed upon awakening, in as many as 73 percent of patients in some reports, although in the Ischemic Optic Neuropathy Decompression Trial (IONDT) symptoms first present on awakening were reported in just 42 percent [2,3]. The vision loss is typically reported as diffuse blurring or cloudiness in the affected eye; some patients may report altitudinal loss or a scotoma. It is common for visual loss to progress over the first few days; in one study the average time to peak vision loss was about five days [4]. Most patients stabilize in one to two weeks [2,5].
It is rare for the symptoms to occur in both eyes at the same time. In one series, 11 percent had a bilateral presentation, but most of these cases occurred in the setting of severe blood pressure fluctuations (eg, surgery, dialysis) [6]. (See "Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Etiology and risk factors'.)
Subscribers log in here